American Chipmakers Had a Toxic Problem. Then They Outsourced It

Results in epidemiology often are equivocal, and money can cloud science (see: tobacco companies vs. cancer researchers). Clear-cut cases are rare.

Read More

Image courtesy of: Cam Simpson